Shinva Medical Instrument (600587) Fundamentals 2026 — P/E 16.0x, Revenue Analysis | SniperIQ
Shinva Medical Instrument (600587) is a CN-listed Healthcare company in Medical - Devices with a market capitalization of ¥7.8B, trading at ¥12.81 on the SHH. This SniperIQ fundamentals page covers Shinva Medical Instrument's valuation (P/E 16.0x, P/B 1.0x), profitability (net margin 5.1%), revenue (¥9.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shinva Medical Instrument's market cap?
Shinva Medical Instrument (600587) has a market capitalization of approximately ¥7.8B, trading at ¥12.81 on the SHH. Market cap moves with the live share price.
What is Shinva Medical Instrument's P/E ratio?
Shinva Medical Instrument's trailing twelve-month P/E ratio is 16.0x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shinva Medical Instrument?
Shinva Medical Instrument runs a net profit margin of 5.1%, a gross margin of 25.4%, and an operating margin of 5.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shinva Medical Instrument generate?
Shinva Medical Instrument reported revenue of ¥9.7B for fiscal year 2025, with net income of ¥526M and earnings per share (EPS) of 0.87. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shinva Medical Instrument pay a dividend?
Shinva Medical Instrument offers a trailing dividend yield of about 2.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shinva Medical Instrument financially healthy?
Shinva Medical Instrument carries a debt-to-equity ratio of 0.18x and a current ratio of 1.41x, with a market beta of 0.23. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shinva Medical Instrument a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shinva Medical Instrument (600587) the key facts are: market cap ¥7.8B, P/E 16.0x, revenue ¥9.7B, 52-week range 11.4-18.62. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shinva Medical Instrument's full fundamentals live
Get Shinva Medical Instrument's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.